Subjects: Drugs, Investigational - Digital Collections - National Library of Medicine Search Results

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NLM Digital Collections

Start Over Subjects Drugs, Investigational

11. Benefit-risk assessment for new drug and biological products: guidance for industry

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, October 2023
Subject(s):: Biological Products
Drug Approval
Drug Industry
Drugs, Investigational
Government Regulation
Pharmaceutical Preparations
Risk Assessment
United States

12. Institutional review board (IRB) review of individual patient expanded access submissions for investigational drugs and biological products: guidance for IRBs and clinical investigators

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, September 2023
Subject(s):: Biological Products
Compassionate Use Trials
Drug Industry
Drugs, Investigational
Ethics Committees, Research
Government Regulation
United States

13. Population pharmacokinetics

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, February 2022
Subject(s):: Clinical Trials as Topic
Drug Approval
Drug Development
Drugs, Investigational
Pharmacokinetics
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

14. National women's health action at the F.D.A. Sept. 20, 1994

Publication:: [United States : s.n.], 1994
Subject(s):: Women's Health
Drug Approval
Drug Industry
Drugs, Investigational
United States. Food and Drug Administration

15. In development, new cancer medicines for older Americans

Publication:: [Washington, D.C.] : Pharmaceutical Manufacturers Association, c1989
Subject(s):: Aged
Antineoplastic Agents
Drug Evaluation
Drugs, Investigational
United States

16. Address Presented at the Festschrift to Honor Dr. Philip L. Calcagno, Washington, DC

Publication:: Produced: 10 June 1988
Subject(s):: Acquired Immunodeficiency Syndrome
Pediatrics
Drugs, Investigational
Social Environment
Archival Collection:: The C. Everett Koop Papers (Profiles in Science)

17. FDA oversight

Author(s):: White, Robert S., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 20-December-2021
Subject(s):: Drug Approval
Drug Therapy
Drugs, Investigational
Government Regulation
Illicit Drugs
United States
United States. Food and Drug Administration